Switch theme
Sign up to access all valuation multiples
Optomed PLC is a Finnish medical technology company and a manufacturer of handheld fundus cameras and screening software. The company operates in two business segments which are Devices and Software. Devices segment develops, commercializes, and manufactures easy-to-use and affordable handheld fundus cameras, that are suitable for any clinic for screening of various eye diseases, such as diabetic retinopathy, glaucoma, and AMD. The Software segment develops and commercializes screening software for diabetic retinopathy and cancer screening for healthcare organizations. The company operates in Finland, China, and other countries.
2004
115
LTM Revenue $17.0M
LTM EBITDA -$3.0M
$69.2M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Optomed has a last 12-month revenue of $17.0M and a last 12-month EBITDA of -$3.0M.
In the most recent fiscal year, Optomed achieved revenue of $16.2M and an EBITDA of -$3.1M.
Optomed expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Optomed valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $16.2M | $16.2M | XXX | XXX | XXX |
| Gross Profit | $9.9M | $11.0M | XXX | XXX | XXX |
| Gross Margin | 61% | 68% | XXX | XXX | XXX |
| EBITDA | -$2.3M | -$3.1M | XXX | XXX | XXX |
| EBITDA Margin | -14% | -19% | XXX | XXX | XXX |
| Net Profit | -$5.9M | -$4.8M | XXX | XXX | XXX |
| Net Margin | -36% | -30% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Optomed's stock price is EUR 4 (or $4).
Optomed has current market cap of EUR 71.1M (or $76.3M), and EV of EUR 64.4M (or $69.2M).
See Optomed trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $69.2M | $76.3M | XXX | XXX | XXX | XXX | $-0.30 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Optomed has market cap of $76.3M and EV of $69.2M.
Optomed's trades at 4.1x LTM EV/Revenue multiple, and -22.9x LTM EBITDA.
Analysts estimate Optomed's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Optomed and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $69.2M | XXX | XXX | XXX |
| EV/Revenue | 4.3x | XXX | XXX | XXX |
| EV/EBITDA | -22.5x | XXX | XXX | XXX |
| P/E | -13.0x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -17.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpOptomed's NTM/LTM revenue growth is 26%
Optomed's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Optomed's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Optomed's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Optomed and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 0% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -19% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 35% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 7% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 5% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 8% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 104% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Optomed acquired XXX companies to date.
Last acquisition by Optomed was XXXXXXXX, XXXXX XXXXX XXXXXX . Optomed acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Optomed founded? | Optomed was founded in 2004. |
| Where is Optomed headquartered? | Optomed is headquartered in Finland. |
| How many employees does Optomed have? | As of today, Optomed has 115 employees. |
| Is Optomed publicy listed? | Yes, Optomed is a public company listed on HEL. |
| What is the stock symbol of Optomed? | Optomed trades under OPTOMED ticker. |
| When did Optomed go public? | Optomed went public in 2019. |
| Who are competitors of Optomed? | Similar companies to Optomed include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Optomed? | Optomed's current market cap is $76.3M |
| What is the current revenue of Optomed? | Optomed's last 12-month revenue is $17.0M. |
| What is the current EBITDA of Optomed? | Optomed's last 12-month EBITDA is -$3.0M. |
| What is the current EV/Revenue multiple of Optomed? | Current revenue multiple of Optomed is 4.1x. |
| What is the current EV/EBITDA multiple of Optomed? | Current EBITDA multiple of Optomed is -22.9x. |
| What is the current revenue growth of Optomed? | Optomed revenue growth between 2023 and 2024 was 0%. |
| Is Optomed profitable? | Yes, Optomed is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
